These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24631054)

  • 1. Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A.
    Anish C; Upadhyay AK; Sehgal D; Panda AK
    Int J Pharm; 2014 May; 466(1-2):198-210. PubMed ID: 24631054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
    Katare YK; Panda AK
    Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
    Katare YK; Muthukumaran T; Panda AK
    Int J Pharm; 2005 Sep; 301(1-2):149-60. PubMed ID: 16023313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs.
    Tewa-Tagne P; Degobert G; Briançon S; Bordes C; Gauvrit JY; Lanteri P; Fessi H
    Pharm Res; 2007 Apr; 24(4):650-61. PubMed ID: 17318421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation.
    Belotti S; Rossi A; Colombo P; Bettini R; Rekkas D; Politis S; Colombo G; Balducci AG; Buttini F
    Eur J Pharm Biopharm; 2015 Jun; 93():165-72. PubMed ID: 25845771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
    Cheow WS; Ng ML; Kho K; Hadinoto K
    Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of operating and formulation variables on the morphology of spray-dried protein particles.
    Maa YF; Costantino HR; Nguyen PA; Hsu CC
    Pharm Dev Technol; 1997 Aug; 2(3):213-23. PubMed ID: 9552449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF; Zhao L; Payne LG; Chen D
    J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
    Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
    J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles.
    Kunda NK; Alfagih IM; Miyaji EN; Figueiredo DB; Gonçalves VM; Ferreira DM; Dennison SR; Somavarapu S; Hutcheon GA; Saleem IY
    Int J Pharm; 2015 Nov; 495(2):903-12. PubMed ID: 26387622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray-dried microparticles containing polymeric nanocapsules: formulation aspects, liquid phase interactions and particles characteristics.
    Tewa-Tagne P; Briançon S; Fessi H
    Int J Pharm; 2006 Nov; 325(1-2):63-74. PubMed ID: 16872767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenic characteristics associated with multivalent display of Vi polysaccharide antigen using biodegradable polymer particles.
    Anish C; Goswami DG; Kanchan V; Mathew S; Panda AK
    Biomaterials; 2012 Oct; 33(28):6843-57. PubMed ID: 22748669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
    Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
    Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization.
    Gupta RK; Goswami DG; Singh RR; Surolia A; Panda AK
    Eur J Pharm Sci; 2012 Feb; 45(3):282-95. PubMed ID: 22155747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine.
    Nayak B; Ray AR; Panda AK; Ray P
    J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel powder formulations for controlled delivery of poorly soluble anticancer drug: application and investigation of TPGS and PEG in spray-dried particulate system.
    Mu L; Teo MM; Ning HZ; Tan CS; Feng SS
    J Control Release; 2005 Apr; 103(3):565-75. PubMed ID: 15820404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
    Katare YK; Panda AK
    Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.